Abstract

Food allergy (FA) and, in particular, IgE-mediated cow’s milk allergy is associated with compositional and functional changes of gut microbiota. In this study, we compared the gut microbiota of cow’s milk allergic (CMA) infants with that of cow’s milk sensitized (CMS) infants and Healthy controls. The effect of the intake of a mixture of Bifidobacterium longum subsp. longum BB536, Bifidobacterium breve M-16V and Bifidobacterium longum subsp. infantis M-63 on gut microbiota modulation of CMA infants and probiotic persistence was also investigated. Gut microbiota of CMA infants resulted to be characterized by a dysbiotic status with a prevalence of some bacteria as Haemophilus, Klebsiella, Prevotella, Actinobacillus and Streptococcus. Among the three strains administered, B. longum subsp. infantis colonized the gastrointestinal tract and persisted in the gut microbiota of infants with CMA for 60 days. This colonization was associated with perturbations of the gut microbiota, specifically with the increase of Akkermansia and Ruminococcus. Multi-strain probiotic formulations can be studied for their persistence in the intestine by monitoring specific bacterial probes persistence and exploiting microbiota profiling modulation before the evaluation of their therapeutic effects.

Highlights

  • We evaluated the persistence of a probiotic mix in the gastrointestinal tract of cow’s milk allergic (CMA)

  • Ninety–seven patients were excluded: 14 were treated with proton-pump inhibitors (PPI), 22 were still partially breastfed, 38 had taken a course of antibiotic therapy in the previous 6 months, 52 had probiotics and 55 had functional foods in the last 2 months; 67 infants had more than one reason for exclusion

  • Our results indicate that B. infantis could have the biological plausibility for therapeutic actions for CMA infants, while the two other strains administered probably do not

Read more

Summary

Introduction

Understanding CMA etiology is needed for the management and prevention of the disease and its later impact on patients

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call